CAS: 173614-88-5

2,3-Didehydrosomnifericin

2,3-Didehydrosomnifericin is a compound isolated from Pteris oleifera, a plant of the Solanaceae family.

2,3-Didehydrosomnifericin is a glycosylated macrolide, which is derived from the secondary metabolites produced by the bacterial genus Actinomycetes. This compound belongs to a class of molecules that are typically synthesized through complex pathways involving polyketide synthases and glycosyltransferases within these microorganisms. The mode of action of 2,3-Didehydrosomnifericin involves inhibition of bacterial protein synthesis. It achieves this by binding to the bacterial ribosome, thus interfering with the translation process. This interaction results in a disruption of cellular functions essential for bacterial growth and survival, highlighting its potential as an antibiotic agent. The primary use of 2,3-Didehydrosomnifericin is in experimental microbiology and antibiotic research. Its unique molecular structure and bioactivity profile make it a subject of interest in the study of resistance mechanisms and the design of new antibiotics. Additionally, it may serve as a lead compound for the development of novel therapeutic agents targeting resistant bacterial strains, offering a valuable tool for scientists exploring new avenues in antimicrobial therapy.